Envista Holdings Co. (NYSE:NVST) Stock Position Cut by Harbor Capital Advisors Inc.

Harbor Capital Advisors Inc. trimmed its stake in shares of Envista Holdings Co. (NYSE:NVST) by 15.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 342,351 shares of the company’s stock after selling 62,238 shares during the quarter. Harbor Capital Advisors Inc.’s holdings in Envista were worth $6,604,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently made changes to their positions in the stock. First Hawaiian Bank raised its position in Envista by 19.9% in the fourth quarter. First Hawaiian Bank now owns 32,285 shares of the company’s stock worth $623,000 after acquiring an additional 5,363 shares in the last quarter. GAMMA Investing LLC raised its holdings in shares of Envista by 30.5% in the 4th quarter. GAMMA Investing LLC now owns 2,304 shares of the company’s stock worth $44,000 after purchasing an additional 538 shares in the last quarter. Franklin Resources Inc. lifted its stake in Envista by 26.5% during the third quarter. Franklin Resources Inc. now owns 3,971,662 shares of the company’s stock valued at $78,480,000 after purchasing an additional 830,861 shares during the last quarter. Sanctuary Advisors LLC bought a new stake in Envista during the third quarter worth approximately $228,000. Finally, Geode Capital Management LLC grew its position in Envista by 2.5% in the third quarter. Geode Capital Management LLC now owns 2,895,653 shares of the company’s stock worth $57,233,000 after buying an additional 71,435 shares during the last quarter.

Envista Trading Down 3.0 %

NYSE NVST opened at $18.60 on Friday. The company has a current ratio of 2.08, a quick ratio of 1.77 and a debt-to-equity ratio of 0.42. Envista Holdings Co. has a 1-year low of $15.15 and a 1-year high of $25.45. The firm’s fifty day simple moving average is $20.19 and its 200-day simple moving average is $18.58. The company has a market capitalization of $3.20 billion, a PE ratio of -2.39, a price-to-earnings-growth ratio of 2.71 and a beta of 1.33.

Envista (NYSE:NVST) last posted its quarterly earnings results on Wednesday, October 30th. The company reported $0.12 earnings per share for the quarter, topping analysts’ consensus estimates of $0.09 by $0.03. The company had revenue of $601.00 million during the quarter, compared to the consensus estimate of $590.34 million. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The business’s quarterly revenue was down 4.8% on a year-over-year basis. During the same period last year, the business earned $0.43 EPS. As a group, sell-side analysts anticipate that Envista Holdings Co. will post 0.72 earnings per share for the current fiscal year.

Analyst Ratings Changes

NVST has been the subject of several research reports. Robert W. Baird raised their price objective on Envista from $17.00 to $22.00 and gave the stock a “neutral” rating in a research note on Thursday, October 31st. Mizuho initiated coverage on Envista in a research report on Wednesday, December 4th. They issued an “underperform” rating and a $20.00 price target for the company. Needham & Company LLC restated a “hold” rating on shares of Envista in a report on Thursday, October 31st. Wells Fargo & Company started coverage on shares of Envista in a report on Tuesday, October 8th. They issued an “equal weight” rating and a $20.00 target price for the company. Finally, Evercore ISI boosted their price target on shares of Envista from $18.00 to $23.00 and gave the company an “outperform” rating in a report on Monday, September 23rd. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $20.21.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.